Skip to main content

Centaurus Financial, Inc.

SEC CIK
0000891943
Latest filing
Aug 17, 2026

DNA holding history

Ginkgo Bioworks Holdings, Inc. in every 13F filed by Centaurus Financial, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNA overviewAll 13F holders of DNAFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q4 2022
Holdings of DNA by Centaurus Financial, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−20,000−100.0%Sold outHolders
Q4 202320,000$34.0K<0.1%+7,000+53.8%AddedHolders
Q3 202313,000$24.0K<0.1%+13,000NewHolders
Q2 20230$00.0%−13,500−100.0%Sold outHolders
Q1 202313,500$18.0K<0.1%+2,000+17.4%AddedHolders
Q4 202211,500$19.0K<0.1%+11,500NewHolders